Acadia Announces Additions to Executive Team
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced two new appointments to its executive team.
- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced two new appointments to its executive team.
- Following a transition period, Austin D. Kim, Executive Vice President, General Counsel and Secretary will be leaving Acadia to pursue other opportunities.
- “I’m thrilled to announce these two important additions to the team,” said Steve Davis, Chief Executive Officer.
- “Jennifer brings strong executive leadership skills with over 20 years of legal, strategy and business experience at emerging, rapidly growing and Fortune 500 life sciences companies.